DEV ENVIRONMENT — dev.library.globalcastmd.com — Changes here do not affect production
Playing from staycurrentmd
8 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Update Course Rewind 2025: Botox for Hirschsprung’s: Where, When, and Why

Video Published 2026-05-15 Updated 2026-06-10

Timestops (5)

Topic Overview

Cincinnati Children's study shows Botox injection during Hirschsprung pull-through reduces enterocolitis risk from 30% to 0% within 31 days post-op. Optimal dosing and injection technique remain unstandardized, though ultrasound guidance is increasingly used for precise sphincter targeting.

Key Takeaways

  • Botox injection during Hirschsprung pull-through reduces enterocolitis risk in first 31 days (0% vs 30% in Cincinnati study)
  • 24% of centers now inject Botox during pull-through procedures, though practice remains variable across institutions
  • Optimal Botox dosing and injection technique lack evidence-based guidelines; ultrasound guidance aids precision but requires expertise
  • Botox use during pull-through associated with increased diaper rash incidence, requiring counseling and management strategies
  • Multi-center data needed to standardize Botox protocols for Hirschsprung surgery including units, frequency, and injection sites

Keywords

Hashtags

Transcript

Comments

Loading comments…